Josh Mandel-Brehm, CEO: Camp4 Therapeutics CAMP Buy · Filed 25/09/11

Trade details

Type: Insider buy
Amount: $9,999
Shares · price: 6,060 sh · $1.65 a share
Held after: 278,417 sh
Stock: Camp4 Therapeutics CAMP
Person: Josh Mandel-BrehmCEO
Trade date: 25/09/11
Filed: 25/09/11
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 19 insiders
Holding change: +2.2%

Camp4 Therapeutics trades, last 26 weeks

What else happened in Camp4 Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/12~25/10/11

Josh Mandel-Brehm's recent trades

No other trades yet.